ChristinaSChuMD
Obstetrics & Gynecology • Camden, NJGynecologic Oncology
Attending Physician, Gynecologic Cancer, MD Anderson Cancer Center at Cooper
Dr. Chu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Cooper Plaza
Camden, NJ
Camden, NJ 08103Phone+1 856-735-6209
Summary
- Dr. Christina Chu is a gynecologic oncologist in Camden, NJ and is affiliated with MD Anderson Cancer Center at Cooper. She received her medical degree from Perelman School of Medicine at the University of Pennsylvania and has been in practice 22 years. She specializes in gynecologic oncology and is experienced in the multidisciplinary treatment of ovarian, cervical, uterine, vaginal, and vulvar cancers and preinvasive disease. Her practice encompasses surgical treatment as well as administration of chemotherapy, as well as clinical trials for cancer treatment. She has more than 60 publications and over 500 citings.
Education & Training
University of Pennsylvania Health SystemFellowship, Gynecologic Oncology, 1999 - 2002- University of Pennsylvania Health SystemResidency, Obstetrics and Gynecology, 1995 - 1999
Perelman School of Medicine at the University of PennsylvaniaClass of 1995
Certifications & Licensure
NJ State Medical License 2004 - 2025
PA State Medical License 1996 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Super Doctor SuperDoctors.com
Clinical Trials
- Ovarian Cancer and Immune Response to Flu Vaccine Start of enrollment: 2006 Oct 01
- Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients Start of enrollment: 2005 Aug 01
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3 Start of enrollment: 2008 May 01
- Join now to see all
Publications & Presentations
PubMed
- A Randomized, Controlled Trial Evaluating Perioperative Risk-Stratification and Risk-Based, Protocol-Driven Management After Elective Major Cancer Surgery.Nestor F Esnaola, Raju Chelluri, Jason Castellanos, Ariella Altman, David Y T Chen
Annals of Surgery. 2024-07-24 - 2 citationsStarting the Conversation: randomized pilot trial of an intervention to promote effective clinical communication about sexual health for gynecologic cancer survivors.Jennifer Barsky Reese, Sharon L Bober, Kristen A Sorice, Elizabeth Handorf, Christina S Chu
Journal of Cancer Survivorship. 2024-06-01 - 1 citationsTransition to Value-based Healthcare: Development, Implementation, and Results of an Optimal Surgical Care Framework at a National Cancer Institute-designated Comprehe...Randall A Lee, Selma Masic, Joseph Bland, Elizabeth Handorf, Alexander Kutikov
European Urology Focus. 2024-01-01
Press Mentions
Temple Physicians Learn Mindfulness to Cope with the Trauma of Treating COVIDJuly 4th, 2021
HPV in Pregnant Women Linked to Miscarriages & Preterm Births, Study ShowsMarch 5th, 2020
HPV Tied to Miscarriages and Preterm BirthsMarch 4th, 2020- Join now to see all
External Links
- Christina Chu MD, Fox Chase Cancer Centerhttps://www.foxchase.org/christina-chu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
